Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 06:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at

Subscribe to WSJ:

Stocks mentioned in the article : Bayer AG, SANOFI
Recommend :
React to this article
Latest news on BAYER AG
4h ago Bayer hits record high on move to list plastics business
4h ago BAYER : eyes MaterialScience float in 12-18 months
5h agoDJEUROPE MARKETS : Banks Climb After TLTRO, Siemens Slips: Europe's Big Stock Move..
5h agoDJEUROPE MARKETS : European Stocks Rally After Fed, ECB News
7h ago BAYER : Conference Call -- “Transforming Bayer into a Pure Life Science Co..
8h ago BAYER : says both IPO and spin-off are options for plastics unit
10h agoDJEUROPE MARKETS : Banks Climb After TLTRO, Siemens Slips: Europe's Big Stock Move..
10h ago BAYER : Athenix Assigned Patent
10h ago BAYER : to split off polymer division with IPO
14h ago BAYER : Aktiengesellschaft: Bayer Board of Management plans to focus entirely on..
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
Bayer AG : Income Statement Evolution
More Financials
Dynamic quotes